1 / 36

Chapter 23 pp 643-650 Chapter 52 Management of Patients With HIV Infection and AIDS

Inflammation Unit II Lecture 3 Lee Resurreccion. Chapter 23 pp 643-650 Chapter 52 Management of Patients With HIV Infection and AIDS . Mycobacterium Tuberculosis (TB).

ziya
Download Presentation

Chapter 23 pp 643-650 Chapter 52 Management of Patients With HIV Infection and AIDS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Inflammation Unit II Lecture 3 Lee Resurreccion Chapter 23 pp 643-650 Chapter 52Management of Patients With HIV Infection and AIDS

  2. Mycobacterium Tuberculosis (TB) • Infectious disease caused by Mycobacterium tuberculosis. Usually involves lungs but it also occurs in kidneys, bones, adrenal glands, lymph nodes and meninges. • Gram positive, acid-fast bacillus • Spread via airborne droplets • Can be inhaled • Repeated close contact, not highly infectious • Bacilli are inhaled, pass down bronchial system and implant on bronchioles or alveoli (lower lungs usual site)

  3. Mycobacterium Tuberculosis (TB) Clinical Manifestations Free of symptoms during early stages • Cough • Becomes frequent with mucoid or mucopurulent sputum. • Dyspnea unusual • Fatigue • Malaise • Anorexia • Weight loss (late) • Low-grade fever • Night sweats

  4. Mycobacterium Tuberculosis (TB) • Tuberculin skin testing (PPD or Mantoux test)) purified protein derivative • Positive 2-12 wks after initial infection • + reaction doesn’t say if dormant or active • Response to TB skin testing decreased in the immunocompromised patient; reactions equal to or greater than 5 mm are considered positive (normally 10-15 cm) • TB sensitivity is LIFELONG! • Chest X-ray: multinodular lymph node involvement, cavitation upper lobes • Bacteriologic studies: • Sputum smear • Sputum culture (MOST ACCURATE)-takes 6-8 weeks for growth • The QuantiFERON-TB Gold (QFT-G) detects TB, and is not affected by prior BCG vaccination. Results in 24 hours

  5. Mycobacterium Tuberculosis (TB) • Active TB should be managed aggressively. • Standard therapy a combination of drugs. Decreases the development of resistant strains. • 6-12 months • Five drugs used: • (****Liver Effects****) • Isoniazid (INH) • Rifampin • Pyrazinamide • Streptomycin • Ethambutol

  6. Transmission of HIV • Transmitted by body fluids containing HIV or infected CD4 lymphocytes • Blood, seminal fliud, vaginal secretions, amniotic fluid, and breast milk • Most prenatal infections occur during delivery • Casual contact does not cause transmission • Breaks in skin and mucosa increase risk

  7. High-Risk Behaviors/Prevention • Sharing infected injection equipment • Having sexual relations with infected individuals • Prevention • Standard precautions: • Practice safer sex practices and safer behaviors • Abstain from sharing sexual fluids • Reduce the number of sexual partners to one • Always use latex condoms; if allergic to latex, use nonlatex condoms • Do not share drug injection equipment • Blood screening and treatment of blood products

  8. Structure of HIV-1

  9. Life Cycle of HIV-1

  10. Stages of HIV Disease • Primary infection • HIV asymptomatic • HIV symptomatic • AIDS

  11. Contributing Factors for Transmission • Duration and frequency of contact • Volume of fluid • Virulence and concentration • Viral Set Point (viral load)= amount of virus in blood • Viral Set Point in the blood, semen, vaginal secretions or breast milk of the donor is an important variable • Large amounts of viral set point first 2 to 6 months after infection and during late stages of the disease • Host immune defense capability

  12. T cells • T lymphocytes are made in the bone marrow (B lymphocytes) but migrate to the Thymus, hence called “T” cells • T cells compose 70-80% of circulating lymphocytes and are primarily responsible for immunity to intracellular viruses, tumor cells and fungi • Live for a few months to lifespan (a normal CD4 T cells lifespan= 100 days, one infested with HIV=2 days) • T cytotoxic- attack antigens on cell membrane of foreign pathogens and release cytotoxic substances that destroy pathogen • T suppressor (CD8) • T helper (CD4)-regulation of cell mediated immunity abdhumoral antibody response • Normal ratio of CD4 to CD8 T cells is 2 CD4 to every 1 CD8. In Later stages of HIV this reverses. • Normal CD4+ T cells: 800 to 1200/µl • Generally, immune system will stay healthy with greater than 500 /µl.

  13. Viral Set Point/Viral Load

  14. Table 52-1 Brunner, p.1823 • Classification System for HIV Infection and Expanded AIDS Surveillance Case Definition for Adolescents and Adults

  15. Primary Infection • Acute HIV infection/acute HIV syndrome • Part of CDC category A • Symptoms: none to flu-like syndrome • Window period: lack of HIV antibodies • Period of rapid viral replication and dissemination through the body • Seroconversion occurs (development of HIV-specific antibodies) • Flu like symptoms, generally mild (called “acute retroviral syndrome”) • Occurs 1 to 3 weeks after infection • Lasts 1 to 2 weeks, symptoms can continue for several months • High level of HIV in the blood • CD4 T cell counts fall temporarily but return to baseline

  16. HIV Asymptomatic • CDC category A • More than 500 CD4+ T lymphpocytes/mm3 • Upon reaching the viral set point, chronic asymptomatic state begins • Body has sufficient immune response to defend against pathogens

  17. HIV Symptomatic • CDC category B • 200 to 499 CD4+ lymphpocytes/mm3 • CD4 T cells gradually fall • The patient develops symptoms or conditions related to the HIV infection that are not classified as category C conditions • Patients who are once treated for a category B condition are considered category B

  18. AIDS • CDC category C • Less than 200 CD4+ lymphocytes/mm3 • As levels drop below 100 cells/mm3, the immune system is significantly impaired • Development of listed conditions

  19. Treatment • Treatment and protocols are continually evolving • Antiretroviral agents: see Table 52-3 • Nucleoside reverse transcriptase inhibitors (NRTIs) • Non-nucleoside reverse transcriptase inhibitors (NNRTIs) • Protease inhibitors (PIs) • Fusion inhibitors • Use of combination therapy • Management focuses upon the treatment of specific manifestations and conditions related to the disease

  20. Manifestations of AIDS—Respiratory • Pneumocystiscarinii pneumonia (PCP) • Most common infection • Initial symptoms may be nonspecific and may include nonproductive cough, fever chills, dyspnea, and chest pain • If untreated, progresses to pulmonary impairment and respiratory failure • Treatment: TMP-SMZ or pentamidine; prophylactic TMP-SMZ • Mycobacterium avium complex (MAC) • Tuberculosis

  21. Manifestations of AIDS—GI • Oral candidiasis • May progress to esophagus and stomach • Treatment with Mycelex troches or nystatin and ketoconazole • Diarrhea related to HIV infection or enteric pathogens • Octreotide acetate for severe chronic diarrhea • Wasting syndrome • 10% weight loss and chronic diarrhea or chronic weakness and fever with absence of other cause • Protein energy malnutrition • Anorexia, diarrhea, GI malabsorption, and lack of nutrition may contribute

  22. Manifestations of AIDS—Oncologic • Kaposi's sarcoma • Cutaneous lesions but may involve multiple organ systems • Lesions cause discomfort, disfigurement, ulceration, and potential for infection • B cell lymphomas

  23. Lesions of Kaposi’s Sarcoma

  24. Manifestations of AIDS—Neurologic • HIV encephalopathy • Progressive cognitive, behavioral, and motor decline • Probably directly related to the HIV infection • Cryptococcus neoformans • Other neurologic disorders • Depression

  25. Nursing Process—Assessment of the Patient With AIDS • Assess physical and psychosocial status • Identify potential risk factors: IV drug abuse and risky sexual practices • Assess immune system function • Assess nutritional status • Assess skin integrity • Assess respiratory status and neurologic status • Assess fluid and electrolyte balance • Assess knowledge level

  26. Nursing Process—Diagnosis of the Patient With AIDS • Impaired skin integrity • Diarrhea • Risk for infection • Activity intolerance • Disturbed thought processes • Ineffective airway clearance • Pain • Imbalanced nutrition • Social isolation • Anticipatory grieving • Deficient knowledge

  27. Collaborative Problems/Potential Complications • Opportunistic infections • Impaired breathing or respiratory failure • Wasting syndrome • Fluid and electrolyte imbalance • Adverse reaction to medication

  28. Nursing Process—Planning the Care of the Patient With AIDS • Goals may include: • Achievement and maintenance of skin integrity • Resumption of usual bowel patterns • Absence of infection • Improved activity tolerance • Improved thought processes • Improved airway clearance

  29. Nursing Process—Planning the Care of the Patient With AIDS (cont.) • Goals may include (cont.) • Increased comfort • Improved nutritional status • Increased socialization • Expression of grief • Increased knowledge regarding disease prevention and self-care • Absence of complications

  30. Skin Integrity • Conduct frequent routine assessment of skin and mucosa • Encourage patient to maintain balance between rest and activity • Reposition at least every two hours and as needed • Use pressure reduction devices • Instruct patient to avoid scratching • Use gentle, nondrying soaps or cleansers • Avoid adhesive tape • Provide perianal skin care

  31. Promoting Usual Bowel Pattern • Assess bowel pattern and factors that may exacerbate diarrhea • Avoid foods that act as bowel irritants, such as raw fruits and vegetables, carbonated beverages, spicy foods, and foods of extreme temperatures • Small, frequent meals • Administer medications as prescribed • Assess and promote self-care strategies to control diarrhea

  32. Activity Intolerance • Maintain balance between activity and rest • Instruction regarding energy conservation techniques • Relaxation measures • Collaboration with other members of the health care team

  33. Maintaining Thought Processes • Assess mental and neurologic status • Use clear, simple language if mental status is altered • Establish and maintain a daily routine • Use orientation techniques • Ensure patient safety and protect from injury • Implement strategies to maintain and improve functional ability • Instruct and involve family in communication and care

  34. Nutrition • Monitor weight, I&O, dietary intake, and factors that interfere with nutrition • Provide dietary consultation • Control nausea with antiemetics • Provide oral hygiene • Treat oral discomfort • Administer dietary supplements • May require enteral feedings or parenteral nutrition

  35. Decreasing Isolation • Promote an atmosphere of acceptance and understanding • Assess social interactions and monitor behaviors • Allow patient to express feelings • Address psychosocial issues • Provide information related to the spread of infection • Educate ancillary personnel, family, and partners

  36. Other Interventions • Improve airway clearance • Use semi-Fowler's or high-Fowler’s position • Pulmonary therapy; coughing and deep breathing; postural drainage; percussion; and vibration • Ensure adequate rest • Pain • Administer medications as prescribed • Provide skin and perianal care

More Related